
浏览全部资源
扫码关注微信
纸质出版:2013
移动端阅览
何兵,余松涛,吕沐瀚,吴玉云,胡长江,杨仕明.miR-29通过ITGB1抑制胃癌侵袭、转移的分子机制[J].陆军军医大学学报(原第三军医大学学报),2013,35(11):1037-1042.
He Bing,Yu Songtao,Lyu Muhan,Wu Yuyun,Hu Changjiang,Yang Shiming.miR-29 functions as an anti-metastatic microRNA in gastric adenocarcinoma by targeting ITGB1[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(11):1037-1042.
何兵,余松涛,吕沐瀚,吴玉云,胡长江,杨仕明.miR-29通过ITGB1抑制胃癌侵袭、转移的分子机制[J].陆军军医大学学报(原第三军医大学学报),2013,35(11):1037-1042. DOI:
He Bing,Yu Songtao,Lyu Muhan,Wu Yuyun,Hu Changjiang,Yang Shiming.miR-29 functions as an anti-metastatic microRNA in gastric adenocarcinoma by targeting ITGB1[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(11):1037-1042. DOI:
目的 观察miR-29对胃癌细胞体外侵袭力的影响,探讨miR-29通过ITGB1调节胃癌侵袭和转移的具体机制。 方法 通过基因芯片筛选胃癌与癌旁组织中差异性表达的miRNA;采用生物信息学预测ITGB1调控相关miRNA,通过比对上述2个结果,筛选出miR-29;进一步以miR-29 慢病毒及miR-29 mimics过表达miR-29后,用Western blot检测胃癌细胞中ITGB1的表达变化;采用双荧光素酶实验分析miR-29与ITGB1的作用机制;采用 Transwell侵袭实验及划痕实验检测miR-29 慢病毒感染后细胞体外侵袭能力的变化;qRT-PCR 检测60例胃癌患者癌组织和癌旁组织中 miR-29 的表达差异,并分析 miR-29的表达与肝癌患者临床病理之间的关系。 结果 基因芯片及生物信息学预测发现miR-29在胃癌组织里高表达,同时又可能调控ITGB1;双荧光素酶实验证实miR-29可以结合在ITGB1 3′UTR, miR-29 慢病毒及miR-29 mimics过表达miR-29都能在蛋白水平下调ITGB1;qRT-PCR 结果显示miR-29家族3条miRNA在胃癌组织中的相对含量均低于癌旁组织[miR-29a:癌旁(32.01±10.38),癌(14.16±6.25);miR-29b:癌旁(26.95±5.05),癌(9.82±1.86);miR-29c:癌旁(53.56±8.05),癌(16.79±1.97),
P
0.01
]
;进一步统计学分析表明,miR-29a与淋巴结转移有关(
P
0.05),miR-29b在具有远处转移的病例组织中C/P比值较无远处转移的病例组织明显降低(P0.05)。 结论 miR-29可以在转录后水平调控ITGB1的表达,从而抑制胃癌细胞的侵袭和转移。
Objective To investigate the underlying molecular mechanisms of miR-29 regulating ITGB1 in the invasion and migration of gastric adenocarcinoma. Methods MicroRNA array was used to screen out miRNAs which were expressed with significant differences in gastric cancer a
nd paracancer tissue. Bioinformatics was employed to predict the miRNAs related to ITGB1 regulation. Gastric cancer cells were infected by lentiviral vectors or transfected with miR-29 mimics to over-express miR-29. Western blotting was used to detect the changes of ITGB1 in gastric cancer cells. Dual luciferase assay was adopted to analyze the mechanism of miR-29 regulating ITGB1. Transwell invasion assay was accomplished to analyze cell invasion ability. The quantitative real-time polymerase chain reaction (qRT-PCR) was adopted to detect the expression differences of miR-29 in 60 pairs of gastric cancer tissue and adjacent noncancerous tissues. The relationship between the expression and clinical pathological data was analyzed. Results MicroRNA array and bioinformatics prediction results supported that miR-29 was in a low expression in gastric carcinoma
and regulated ITGB1. Dual luciferase assay confirmed that miR-29 was bond to the 3′UTR of ITGB1. Western blotting suggestedthat ITGB1 was down-regulated as miR-29 over-expression. The results of qRT-PCR suggested that the relative expression of miR-29 in gastric cancer tissues was lower than in the adjacent noncancerous tissues (miR-29a: 14.16±6.25
vs
32.01±10.38; miR-29b: 9.82±1.86
vs
26.95±5.05; miR-29c: 16.79±1.97 vs 53.56±8.05
P
0.01). Statistical analysis showed that the expression of miR-29a was closely related with lymph node metastasis (
P
0.05). The expression ratio of miR-29b in gastric cancer tissues to adjacent noncancerous tissues was significantly lower in the tissue with distant metastasis (
P
0.05). Conclusion miR-29 regulates ITGB1 expression at post-transcriptional level
and then suppresses the invasion and metastasis of gastric adenocarcinoma.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621